Related Experiment Video
Updated: Apr 27, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways
Sergej Skvortsov1, Paul Debbage2, Peter Lukas1
1Department of Therapeutic Radiology and Oncology, Innsbruck Medical University, Innsbruck, Austria.
Abstract:
DNA damaging agents (ionizing radiation and chemotherapeutics) are considered as most effective in cancer treatment. However, there is a subpopulation of carcinoma cells within the tumour demonstrating resistance to DNA damaging treatment approaches. It is suggested that limited tumour response to this kind of therapy can be associated with specific molecular properties of carcinoma stem cells (CSCs) representing the most refractory cell subpopulation. This review article presents novel data about molecular features of CSCs underlying DNA damage response and related intracellular signalling.
Insights
Cancer stem cells (CSCs) resist DNA damaging treatments due to unique molecular properties. Understanding these features is key to improving cancer therapy effectiveness against refractory tumor subpopulations.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- DNA damaging agents like ionizing radiation and chemotherapeutics are primary cancer treatments.
- A subpopulation of carcinoma cells within tumors exhibits resistance to these therapies.
- This resistance is linked to the unique molecular characteristics of carcinoma stem cells (CSCs).
Purpose of the Study:
- To review novel data on the molecular features of CSCs.
- To elucidate the mechanisms of DNA damage response in CSCs.
- To explore intracellular signaling pathways involved in CSC resistance.
Main Methods:
- Literature review of recent studies on CSCs and DNA damage response.
- Analysis of molecular properties and signaling pathways in refractory cancer cells.
- Synthesis of current knowledge on CSCs' role in treatment resistance.
Main Results:
- CSCs possess distinct molecular attributes that confer resistance to DNA damaging agents.
- Specific intracellular signaling pathways are implicated in the DNA damage response of CSCs.
- These molecular features contribute to the limited efficacy of conventional therapies against certain tumors.
Conclusions:
- Carcinoma stem cells are a key factor in tumor resistance to DNA damaging treatments.
- Targeting CSC-specific molecular pathways may overcome treatment resistance.
- Further research into CSC biology is crucial for developing more effective cancer therapies.
More Related Videos
08:31Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy
Published on: June 8, 2018
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair